Effects of Aging and the Urinary Microbiome on Recurrent Urinary Tract Infections

衰老和泌尿微生物组对复发性尿路感染的影响

基本信息

  • 批准号:
    9753089
  • 负责人:
  • 金额:
    $ 12.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Urinary tract infections (UTIs) are one of the most commonly diagnosed infections in older adults. UTIs cost $1.6 billion annually, impair health-related quality of life, and can have serious sequellae such as hospitalization, sepsis, or death. At all ages, UTIs are more prevalent in women than men, with up to 50% of all women experiencing a UTI during their lifetime. The incidence of UTI rises in older women with over 10% of women older than 65 and almost 30% of women older than 85 reporting a UTI within the prior 12 months. Among women with UTIs, there exists a subgroup with recurrent UTIs, defined as 3 or more culture proven infections within 12 months, or >2 culture proven infections in a 6 month period. Recurrent UTI is not only more common in women, but especially more common in the post- menopausal life stage. In some women with recurrent UTIs, genetic factors facilitate bacterial adherence and repeated infection. However, recurrent UTI prevalence rises significantly in post- menopausal women, suggesting additional non-genetic mechanisms associated with aging. The urinary microbiome is one potential non-genetic factor that could influence recurrent UTIs with aging. We now have significant evidence that a urinary microbiome exists, and that dysbiosis may be associated with health versus disease. Our long-term goal is to improve our understanding of the microbes that occupy the urinary niche, how these microbes change with aging, and to determine whether particular microbial community types are associated with recurrent UTI. We aim to compare urinary lactobacilli in populations of women without recurrent UTIs to assess how lactobacilli change with aging and with the presence of vaginal estrogen therapy. Next, we aim to assess whether urinary lactobacilli or other microbes are associated with recurrent UTI in postmenopausal women who are using vaginal estrogen. Finally, we aim to determine whether there are distinct microbial community types that are associated with recurrent UTI in older women.
项目总结/摘要 尿路感染是老年人中最常见的感染之一, 成年人了UTI每年花费16亿美元,损害与健康相关的生活质量,并可能导致严重的 后遗症如住院、败血症或死亡。在所有年龄段,UTI在以下人群中更为普遍: 女性多于男性,高达50%的女性在一生中经历过UTI。的 UTI的发病率在老年女性中上升,超过10%的65岁以上的女性和近30%的 年龄超过85岁的女性在过去12个月内报告了UTI。 在患有UTI的女性中,存在一个复发性UTI的亚组,定义为3个或更多 12个月内培养证实感染,或6个月内培养证实感染>2次。 复发性UTI不仅在女性中更常见,而且在术后更常见。 更年期生活阶段在一些患有复发性UTI的女性中,遗传因素促进了细菌感染。 坚持和反复感染。然而,复发性UTI患病率在治疗后显著上升, 绝经期妇女,提示与衰老相关的其他非遗传机制。 尿微生物组是一个潜在的非遗传因素,可能影响复发性 尿路感染伴衰老。我们现在有重要的证据表明,尿液微生物组的存在, 生态失调可能与健康与疾病有关。我们的长期目标是提高我们的 了解占据尿液生态位的微生物,这些微生物如何随着 老化,并确定特定的微生物群落类型是否与 复发性尿路感染我们的目的是比较尿乳酸杆菌在人群中的妇女没有复发 UTI评估乳酸杆菌如何随着年龄的增长和阴道雌激素的存在而变化 疗法接下来,我们的目标是评估尿中乳酸杆菌或其他微生物是否与 使用阴道雌激素的绝经后妇女的复发性UTI。最后,我们的目标是 确定是否有不同的微生物群落类型, 老年女性的复发性UTI。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAZEMA Y SIDDIQUI其他文献

NAZEMA Y SIDDIQUI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAZEMA Y SIDDIQUI', 18)}}的其他基金

Conference for Prolapse Outcome Measurement
脱垂结果测量会议
  • 批准号:
    9754359
  • 财政年份:
    2019
  • 资助金额:
    $ 12.08万
  • 项目类别:
Epigenomics in insulin resistance associated overactive bladder
胰岛素抵抗相关膀胱过度活动症的表观基因组学
  • 批准号:
    9314679
  • 财政年份:
    2017
  • 资助金额:
    $ 12.08万
  • 项目类别:
Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
杜克大学医学中心 (DUMC) 盆底疾病网络 (PFDN) 临床站点
  • 批准号:
    10534486
  • 财政年份:
    2001
  • 资助金额:
    $ 12.08万
  • 项目类别:
Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
杜克大学医学中心 (DUMC) 盆底疾病网络 (PFDN) 临床站点
  • 批准号:
    10684759
  • 财政年份:
    2001
  • 资助金额:
    $ 12.08万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了